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Tie2-R849W Mutant in Venous Malformations
Chronically Activates a Functional STAT1 to
Modulate Gene Expression
Hsiao-Tang Hu1, Yi-Hsien Huang2,6, Yi-Ann Chang1, Chien-Kuo Lee3, Meei-Jyh Jiang4,5 and Li-Wha Wu1,5
Tie2 is an endothelial receptor tyrosine kinase. An amino-acid substitution of tryptophan for arginine at residue
849 (Tie2-R849W) leads to a ligand-independent activation of its kinase activity. This mutation has been
associated with familial venous malformations (VMs), manifested by variable thickness or lack of smooth-
muscle cells in the veins of patient lesions. The underlying mechanism for Tie2-R849W action in endothelial
cells remains elusive. In this study, we used adenoviral infection to differentiate the effects of ectopic Tie2 (wild
type, kinase-dead K855A, or constitutively active R849W) expression on endothelial cellular behaviors and Tie2-
mediated downstream targets. Ectopic Tie2 reduced endothelial cell proliferation and serum withdrawal-
induced apoptosis, while stimulating migration. When comparing R849W with K855A and its wild-type
counterpart, a functional tyrosine kinase activity was required only for migration, and constitutively active Tie2-
R849W conferred highest resistance to serum-induced apoptosis, but lowest ability to maintain tube-like
structures formed on Matrigel. We further demonstrated that Tie2-R849W chronically induced STAT1 tyrosine
phosphorylation and the promoter activity of STAT1-responsive IFN-regulatory factor 1 (IRF1). Although STAT1
phosphorylation required JNK and p38MAPK activation, only JNK activation was essential for IRF1 promoter
activation by Tie2-R849W. Additional studies are needed to study the role of STAT1 activation in VMs.
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INTRODUCTION
Venous malformations (VMs) are localized defects of vascular
morphogenesis. This disease, composed of dilated, serpigi-
nous channels, is the anomaly most commonly seen in
specialized centers. The walls of channels have a variable
thickness of smooth-muscle cells; some mural region
surrounding endothelium even lack smooth-muscle cells.
Although any organ can be affected by VMs, the lesions are
usually located in skin and mucosal membrane (Mulliken,
1988). VMs not only can cause pain and bleeding, but can
also be life threatening in some critical locations. Although
most venous anomalies occur sporadically, families with
dominant inheritance have been identified.
Using linkage analysis, it has been established that some
families with inherited VMs carry a missense mutation,
leading to an arginine-to-tryptophan substitution at position
849 (R849W) in the kinase domain of Tie2. The R849W
mutation causes ligand-independent activation of Tie2
activity (Vikkula et al., 1996). Due to the lack of smooth-
muscle cells in the veins of VMs patients, Tie2-mediated
signaling is suggested to play a critical role in endothelial
cells and their interaction with smooth-muscle communica-
tion in these patients. However, the exact mechanism where
a mutated endothelial Tie2 protein (Tie2-R849W) could have
adverse influence on the thickness of smooth-muscle cells in
the lesion veins remains unknown. Dissecting the Tie2-
R849W-mediated molecular mechanism should thus provide
molecular insights into the pathways responsible for the
etiology of VMs and possible therapeutic targets for treating
these diseases.
Tie2 is a receptor tyrosine kinase and is predominantly
expressed in human endothelial cells (Sato et al., 1993). So
far, four ligands for Tie2 have been characterized, including
angiopoietins (Angs) 1–4 (Davis et al., 1996; Maisonpierre
et al., 1997; Valenzuela et al., 1999). Ang1-knockout mice
display a mutant phenotype similar to Tie2 knockouts. Both
knockouts are embryonic lethal and present a simplified
pattern of vessel branching without the recruitment of
perivascular cells in addition to impaired heart development.
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Together, Tie2/Ang1 signaling appears to control at least two
different signal transduction pathways that affect both
angiogenic sprouting and smooth-muscle cell recruitment
(Dumont et al., 1994; Suri et al., 1996).
More and more receptor tyrosine kinases, like platelet-
derived growth factor receptor and epidermal growth factor
receptor, were reported to phosphorylate the signal transducer
and activator of transcription (STAT) family by a ligand-
dependent activation of their intrinsic kinase activity
(Leaman et al., 1996; Vignais et al., 1996). STATs are latent
cytoplasmic transcription factors and become phosphorylated
at tyrosine upon activation, a post-translational modification
critical for dimerization, nuclear import, DNA binding, and
transcriptional activation. Upon activation, STAT proteins
form homodimeric or heterodimeric complexes that further
translocate to the nucleus and bind specific elements within
the promoters of target genes (Lim and Cao, 2006). One
previous study, using ectopic overexpression of Tie2-R849W
in human kidney embryonic 293 cells, demonstrated distinct
activation of STAT1 by Tie2-R849 mutant but not its wild-type
(WT) counterpart (Korpelainen et al., 1999), suggesting that
distinct signaling R849W-mediated pathways mutant may be
responsible for the etiology of VMs.
We thus undertook adenoviral overexpression of WT Tie2
(Tie2-WT) or its variants (kinase-dead Tie2-K855A and
constitutively active Tie2-R849W) to compare their effects
on endothelial cell behaviors and examine the underlying
mechanism responsible for Tie2-R849W-mediated signaling
pathways.
RESULTS
Ectopic expression of Tie 2 and its variants in lung carcinoma
A549 cells and HUVECs
To determine the function of Tie2-WT, K855A, and R849W
mutants in non-endothelial A549 cells lack of endogenous
Tie2 expression, they were infected with adenovirus at an
multiplicity of infection of 40, achieving 100% infection
efficiency, and protein lysates were harvested for immunopre-
cipitation and western blot analysis. The Tie2 protein was only
present in A549 cells infected with Tie2-bearing adenoviruses.
In the absence of ligand stimulation, overexpressed Tie2-WT
and Tie2-R849W were tyrosine phosphorylated, whereas
kinase-dead Tie2-K855A was not. Although the amount of
Tie2 protein was lowest in Tie2-R849W-infected cells, the
phosphotyrosyl level of Tie2-R849W was highest (Figure 1a).
This finding was consistent with the observation that R849W
mutant had a higher in vitro kinase activity than Tie2-WT
(Vikkula et al., 1996). A similar observation was recapitulated
in human umbilical vein endothelial cells (HUVECs) infected
with Tie2 variants (Figure 1b). We further confirmed ectopic
expression of Tie2 protein on the surface of HUVECs using
flow cytometry (Figure 1c). Together, Tie2-R849W has
constitutively elevated kinase activity and increased receptor
autophosphorylation.
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Figure 1. Tie2-bearing adenoviral infection increased the Tie2 or its variant expression on cell surface. (a) Lysates from adenovirus-infected A549 cells were
harvested at 24-hours post infection for immunoprecipitation with anti-Tie2 antibody, followed by western blot analysis using anti-phosphotyrosine (p-Tie2)
antibody. (b) Lysates from adenovirus-infected HUVECs were harvested for western blot analyses using anti-p-Tie2 or anti-Tie2 antibodies. (c) The infected cells
were harvested at 24-hours post adenoviral infection for cell-surface Tie2 protein labeling using flow cytometry. The values represent mean±SD of three
independent experiments (bottom panel). MFI, mean fluorescence intensity; **Po0.01 versus LacZ; NS, not significant versus Tie2-WT.
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Differential effect of ectopically expressed Tie-2 variants on
HUVECs
Ang1-Tie2 signaling has been shown to play a role in
endothelial proliferation, migration, survival, and differentia-
tion; we next examined whether ectopically expressed Tie2
had any effect in the ability of endothelial cells to proliferate,
respond to serum withdrawal-induced apoptosis, migrate, or
form tubes on Matrigel. Following adenoviral infection, Tie2
variants manifested lower proliferation rate than control cells
infected with AdNull or AdLacZ. However, there was no
significant variation in the proliferation rate among Tie2-
infected cells (Figure 2a). In contrast, all Tie2-infected
cells were significantly protected from apoptosis induced by
24-hour serum withdrawal, indicating a protective function
of Tie2 (Figure 2b). Although kinase activity of Tie2 was
not essential for the protective effect, Tie2-R849W had
the highest ability to block serum withdrawal-induced
apoptosis.
We further measured the ability of Tie2 variant-expressing
HUVECs to migrate or form tubes on Matrigel. No alteration
in the migratory ability of Tie2-WT- and Tie2-R849W-
expressing cells was observed, and an intrinsic tyrosine
kinase activity was required for migration (Figures S1a and b).
Tube formation assay demonstrated that control HUVECs
formed tubes in as short a time as 1 hour after being seeded
on Matrigel (data not shown); tube-forming ability peaked at
6 hours post-seeding and tube-like structures were main-
tained for as long as 36 hours (Figure 2c). Consistent with
Ang1-overexpressing endothelial cells seeded on Matrigel
(Furuta et al., 2006), Tie2-expressing HUVECs tended to form
thicker layers of tube-like structures than control or LacZ cells
(Figure 2c). However, by 36-hour incubation, the tubes
formed by Tie2-R849W cells disintegrated faster than those of
control cells and those bearing Tie2-WT or Tie2-K855A.
Together, Tie2-R849W-expressing HUVECs are more resis-
tant to serum-induced cell death, but are more labile than
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Figure 2. Effect of ectopic Tie or its variants on HUVEC proliferation, apoptosis, migration, and tube formation. (a) Following adenovirus infection,
serum-starved HUVECs were subjected to proliferation assay for 48 hours. (b) The infected cells were serum-deprived for 24 hours to induce apoptosis
for apoptosis assay. (c) Adenovirus-infected HUVECs were seeded on Matrigel for tube formation assay. Images of tube-like structures were taken
at 6 (i–v) and 36hours (vi–x) post-seeding. Quantitative data at 36-hours post-seeding is shown at the bottom. *Po0.05 or **Po0.01 versus LacZ;
yPo0.05 versus Tie2-WT.
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cells expressing Tie2-WT or Tie2-K855A when seeded onto
Matrigel.
Ectopic Tie2-849W induced tyrosine phosphorylation of STAT1
by direct association
Tie2 and its mutated form, Tie2-R849W, differentially
activated STAT proteins in 293T cells co-transfected with
an individual STAT member and Tie2 (Korpelainen et al.,
1999). STAT proteins are initially activated through phos-
phorylation at tyrosine residue 701 (Y701) by cytokines or
growth factors (Wen et al., 1995). Among STAT family
members, STAT1, 3, and 5 are known to mediate inflamma-
tion. We used western blot analysis to examine whether
ectopically expressed Tie2 variants, a mediator of inflamma-
tion (Lemieux et al., 2005; Fiedler and Augustin, 2006), had
any effect on the tyrosine phosphorylation of STAT1, 3, and 5
even in the absence of Ang1 stimulation. A significant
increase in the basal phosphorylation of STAT1 at Y701 was
detected in cells expressing Tie2-R849W, but not Tie2-WT
and Tie2-K855A (Figure 3a). No alteration in the tyrosine
phosphorylation of STAT3 was detected (Figure 3b). How-
ever, little or no STAT5 tyrosine phosphorylation was
observed in HUVECs (data not shown). Although serine
phosphorylation in each STAT protein is also required for
maximal transcriptional activity (Wen et al., 1995), the extent
of serine phosphorylation of STAT1, 3, and 5 was not altered
by any Tie2 protein (data not shown). Similar findings were
obtained in non-endothelial A549 cells (data not shown).
Together, Tie2-R849W chronically induced tyrosine, but not
serine phosphorylation, of STAT1.
Since STAT1 tyrosine phosphorylation occurred only in
Tie2-R849W-expressing cells, STAT1 was a likely substrate of
constitutive Tie2-R849W tyrosine kinase. We used reciprocal
immunoprecipitation to see whether STAT1 and Tie2 were in
the same complex. Following myc-tagged Tie2-WT, K855A,
or R849W-bearing adenoviral infection of HUVECs, protein
lysates were collected for immunoprecipitation with anti-
STAT1 antibodies, followed by western blot analysis of myc-
tagged Tie2 protein. We did observe myc-tagged Tie2 in the
STAT1 immunocomplex (Figure 3c). The interaction of Tie2
and STAT1 was confirmed by reciprocal immunoprecipita-
tion with anti-myc agarose and blotted with anti-STAT1
antibodies (Figure 3d). Although STAT1 constitutively formed
a complex with Tie2, only constitutively active Tie2-R849W
chronically induced STAT1 phosphorylation at tyrosine.
Subcellular localization and transcriptional regulation of
phosphotyrosyl STAT1 induced by Tie2-R849W
STAT1 phosphorylation at Y701 induces nuclear transloca-
tion and DNA binding (Ihle et al., 1994). To examine
subcellular localization of phosphotyrosyl STAT1 induced by
Tie2-R849W, cytosolic and nuclear fractions were isolated
from HUVECs infected with Tie2 variants for western blot
analysis. A significant fraction of Tie2-R849W-induced
phosphotyrosyl STAT1 was present in cell nuclei (Figure 4a).
By contrast, little or no phosphorylated STAT1 was detected
in the nuclei of cells expressing Tie2-WT or Tie2-K855A.
Immunofluorescence microscopy further showed discrete
nuclear localization of phosphotyrosyl STAT1 (Figure 4b). These
data indicate that phosphotyrosyl STAT1 might behave as a
transcription factor to modulate the expression of STAT1-
inducible gene(s) in endothelial cells.
Tyrosine phosphorylation and DNA binding of STATs
correlated with their ability to activate transcription. We
performed STAT1-inducible promoter-driven luciferase assay
to examine whether Tie2 and its variants had any effect on
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Figure 3. Tie2-R849W induced STAT1 tyrosine phosphorylation by direct association with STAT1. (a, b) Total proteins from the indicated adenoviral
infected HUVECs were analyzed by western blot analysis using anti-p-STAT1(Y701), STAT1, p-STAT3(Y705), and STAT3. STAT1 and STAT3 serve
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the expression of STAT1-inducible genes. HUVECs were co-
transfected with STAT1-inducible IFN-regulatory factor 1
(IRF1) or STAT1-insenstive thymidine kinase promoter-driven
reporter constructs together with Tie2-variant expression
vector, followed by luciferase assay. As shown in Figure 4c,
ectopically expressed Tie2-R849W significantly enhanced
IRF1 but not thymidine kinase promoter (a negative control
for STAT1, relative luciferase unit¼2.8±0.08B3.8±0.83)
in both HUVECs and non-endothelial human embryonic
kidney 293 (HEK293) cells, although Tie2-WT also stimulated
IRF1-promoter activity to some extent.
We next used reverse transcriptase-PCR to confirm the
stimulatory effect of Tie2-R849W on the IRF1 promoter.
Following adenoviral infection, cells were treated for 4 hours
with lipopolysaccharide (LPS) (100 ngml1), a known in-
ducer for IRF1. Although Tie2-R849W only increased the
basal expression of IRF1 mRNA by 30–40% (data not shown),
the same protein increased LPS-induced IRF1 mRNA expres-
sion by fourfold (Figure 4d), indicating Tie2-R849W-
sensitized HUVECs to be more responsive to LPS stimulation.
Together, Tie2-R849W modulated the STAT1-inducible
expression of IRF1 by functional activation of STAT1.
Pharmacological inhibition effects of various kinases on the
tyrosine phosphorylation of STAT1- and IRF1-promoter activity
Tie2 activation has been shown to activate mitogen-activated
protein kinases (MAPKs) (Harfouche et al., 2003) and AKT/
PKB (DeBusk et al., 2004), a downstream target of
phosphoinositide-3-kinase. We treated Tie2-R849W-expres-
sing cells for 1 hour with selective inhibitors for MAPKs or
phosphoinositide-3-kinase to examine the effect of kinase
inhibition on Tie2-R849W-induced tyrosine phosphorylation
of STAT1 and IRF1-promoter activity. Following 1-hour
treatment, inhibitors for JNK (SP600125) or p38MAPK
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(SB203580), but not others, differentially attenuated
Tie2-R849W-induced STAT1 phosphorylation, suggesting
participation of JNK and p38MAPK activation in
Tie2-R849W-induced tyrosine phosphorylation of STAT1
(Figure 5a; Figure S2).
We next examined whether JNK or p38MAPK activation
was involved in STAT1-inducible IRF1-promoter activity. We
first confirmed by western blot analysis the effects of kinase
inhibitors on STAT1 tyrosine phosphorylation at the same
time point for the promoter-driven luciferase assay. Following
24-hour inhibitor treatment, JNK inhibitor reduced STAT1
phosphorylation, but p38MAPK inhibitor enhanced the same
(Figure 5b). Consistent with the chronic effect of inhibitors on
STAT1 phosphorylation, JNK inhibitor potently reduced the
induction of IRF-1-promoter activity by Tie2-R849W,
whereas p38MAPK slightly increased its activity (Figure 5c).
Together, although Tie2-R849W mediated tyrosine phos-
phorylation of STAT1 by association in the same protein
complex, both p38- and JNK-mediated signaling pathways
are also involved in the enhanced tyrosine phosphorylation of
STAT1 by Tie2-R849W. However, only JNK activation was
required for STAT1-inducible IRF1-promoter induction in
Tie2-R849W-expressing cells.
DISCUSSION
Tie2-R849W is a constitutively active tyrosine kinase.
Ectopic expression of Tie2-R849W conferred resistance to
serum withdrawal-induced apoptosis on HUVECs, reduced
HUVECs ability to maintain tube-like structures on
Matrigel, and induced more than fourfold enhancement of
LPS-mediated IRF1 induction. Moreover, STAT1 phospho-
rylation at Y701, along with predominant nuclear localization
of STAT1 and activation of STAT1-inducible IRF1 promoter,
were observed in Tie2-R849W-expressing endothelial
cells. Although p38MAPK and JNK activation were involved
in Tie2-R849W-mediated STAT1 phosphorylation, only
JNK activation was required for R849W-induced
IRF1-promoter activity. Whether alterations in endothelial
cell behaviors play any role in the VMs etiology remains
unanswered.
Tie2 activation by Ang1 is involved in cell migration and
survival, but not proliferation (Witzenbichler et al., 1998;
Kim et al., 2000). Ang1/Tie2 mediates cell survival through
ATK activation (Kim et al., 2000). Consistent with constitutive
AKT activation by ligand-independent Tie2-R849W (Morris
et al., 2005), we found that Tie2-R849W-expressing cells
were more resistant to serum-induced apoptosis than their
WT counterparts (Figure 2b). However, Tie2-R849W and
Tie2-WT had no differential effect on cell migration (Figure S1)
and proliferation. Although genetic ablation indicates
Ang1-mediated cell adhesion, integrin, but not its cognate
receptor, Tie2, is required for Ang1-mediated cell adhesion
(Carlson et al., 2001). Moreover, a stable interaction between
integrin and Tie2 regulates cell response to Ang1 (Cascone
et al., 2005). Since kinase-dead Tie2-K855A may behave as a
dominant-negative receptor to inhibit the responsiveness of
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endogenous Tie2 in HUVECs, less responsive Tie2-K855A-
expressing cells may somehow become less motile regardless
of the motogen type (Figure S1). Additional studies are
needed to address this discrepancy.
Tie2-R849W induced STAT1 phosphorylation at Y701
independent of ligand stimulation. STAT1 phosphorylation
was previously shown to occur by two distinct mechanisms,
one by receptor tyrosine kinase and the other by the Janus
kinase (Fujitani et al., 1997). Using reciprocal immuno-
precipitation and western blot analysis, we found constitutive
association of STAT1 with Tie2 receptor regardless of its
genotype. Moreover, no Janus kinase-1 was found in the
STAT1–Tie2 immunocomplex (data not shown). Although
STAT1 constitutively associated with Tie2 or its variants, only
constitutively active Tie2-R849W had the ability to phos-
phorylate STAT1 without ligand stimulation. Taken together,
Tie2-R849W phosphorylated STAT1 at Y701 by direct
interaction, although involvement of Janus kinase members,
other than Janus kinase-1, in STAT1 phosphorylation could
not be ruled out.
STAT1 phosphorylation at Y701 induces nuclear trans-
location and DNA binding (Silvennoinen et al., 1993). We
were able to detect a significant portion of tyrosine
phosphorylated STAT1 residing in the cell nuclei using
cytosol and nuclear fractionation. Immunofluorescence
staining further demonstrated discrete nuclear localization
of phosphotyrosyl STAT1. Consistent with IRF1 being a
downstream target of STAT1 (de Prati et al., 2005), we found
that Tie2-R849W enhanced IRF1-promoter activity in the
endothelial cells. More intriguingly, LPS-induced IRF1
expression was further stimulated fourfold only in Tie2-
R849W-expressing cells. Together, Tie2-R849W induced
functional activation of STAT1, leading to increased expres-
sion of STAT1-responsive gene like IRF1. Gain-of-function
mutation of Tie2 at the residue 849 acquired a new ability to
activate STAT1 and its downstream target(s). DNA microarray
or protein kinase array may be used to address what other
targets are differentially regulated in the cells expressing Tie2-
R849W and Tie2-WT.
In addition to STAT1 activation, activated phosphorylation
of JNK and p38MAPK was also enhanced in Tie2-R849W-
expressing cells when compared with Tie2-WT (Figure S3).
JNK and p38MAPK are shown to participate in STAT1
activation (Xuan et al., 2005; Galdiero et al., 2006).
Pharmacological inhibition of JNK or p38MAPK activation
differentially attenuated the ability of Tie2-R849W to induce
STAT1 tyrosine phosphorylation. Surprisingly, JNK blockage,
but not p38MAPK activation, significantly reduced the
stimulatory effect of Tie2-R849W on the IRF1 promoter
activity, indicating requirement of JNK, but not p38MAPK
activation, for IRF1-promoter stimulation by Tie2-R849W.
Whether Tie2-R849W-induced JNK activation, followed by
stimulation of IRF1 expression, plays any role in familial VMs
harboring Tie2-R849W remains to be characterized. More-
over, an MAPK crosstalk has been described by which one
MAPK can directly inhibit the activity of another MAPK
family member by inhibiting an upstream kinase or activation
of a deactivating phosphatase (Hoefen and Berk, 2002).
Consistent with the notion, JNK was activated in p38MAPK-
deficient cells (Perdiguero et al., 2007). The crosstalk
manifested by JNK-mediated increases in STAT1 tyrosine
phosphorylation and IRF1-promoter activity was also ob-
served in Tie2-R849W cells treated for 24 hours with
p38MAPK inhibitor, compared with those without treatment
(Figure 5b and c).
STAT1 belongs to a family of six members. Korpelainen
et al. previously reported that Tie2 and its constitutively
active counterpart, R849W, potently activate STAT3 and
STAT5 in addition to STAT1 using contransfection of non-
endothelial HEK293 cells with the expression vectors. By
contrast, our study only reported a significant stimulation in
the activated tyrosine phosphorylation level of STAT1 but not
STAT3 nor STAT5. Unlike 293 cells used in their study, no
tyrosine phosphorylation of STAT5 was detected in endothe-
lial cells. These discrepant observations were likely due to
use of different cell types for the studies. We believe that our
study, using endothelial rather than non-endothelial cells, is
more relevant to the reported context-dependent activation of
Ang/Tie2-mediated signaling pathways (Davis et al., 2002).
In summary, our study provides evidence for a functional
STAT1 activation by Tie2-R849W in the context of human
endothelial cells. STAT1 is one major signaling molecule
converting the IFN-g signal into expression of genes related to
the inflammatory process (de Prati et al., 2005). STAT1 was
recently shown to be a negative regulator of angiogenesis
in vitro and in vivo (Battle et al., 2006). Thus, further detailed
studies examining whether chronic STAT1 activation indeed
occurs in familial VMs patients with Tie2-R849 mutation and
also its functional implication in the etiology of VMs, may not
only aid our understanding of how an activated phospho-
rylating Tie2 mutant leads to development of vascular
lesions, but may also facilitate use of STAT1 as a therapeutic
target for treating such patients.
MATERIALS AND METHODS
Antibodies
Anti-Tie2 antibody for western blot analysis was from Santa Cruz
Biotechnology (Santa Cruz, CA), whereas anti-Tie2 antibody for flow
cytometry was from Abcam (Cambridge, UK). Anti-phosphotyrosine
antibody PY20 was from BD Biosciences (San Jose, CA). Phospho-
AKT and AKT, antibody sampler kits for phospho-STAT, STAT,
phospho-MAPK, and MAPK families were from Cell Signaling
(Beverly, MA). Anti-myc agarose beads were from Covance
(Berkeley, CA). Anti-Myc antibody was from Invitrogen
(Carlsbad, CA). Various kinase inhibitors were from Calbiochem
(San Diego, CA).
Culturing and maintenance of cultured cells
Primary HUVECs were obtained from fresh human umbilical veins,
with a slight modification as previously described (Geva and Jaffe,
2000). HUVECs, seeded in dishes precoated with 0.1% gelatin for
1 hour, were routinely maintained in EGM2 containing 2% fetal
bovine serum. To avoid genetic variation resulting from different
individuals, HUVECs from five or more different donors were pooled
together. HUVECs at no more than six passages were used for the
following experiments. Human lung carcinoma A549 and HeLa cells
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were cultured as described by American Type Culture Collection.
HEK293 at p30 passages were maintained in minimal essential
medium supplemented with 10% heat-inactivated horse serum,
1mM sodium pyruvate, 100Uml1 of penicillin, and 0.1mgml1 of
streptomycin. The use of HUVECs for the proposed experiments was
approved by the Institutional Review Board.
Construction of adenoviral vector expressing Tie-2 and its
variants
Human Tie2 cDNA was a generous gift from Regeneron (Tarrytown,
NY). AdNull viruses with no transgene and AdLacZ viruses
expressing LacZ gene were, respectively, generated in a similar
manner. Tie2 mutation (K855A or R849W) was generated using the
QuickChange Site-directed mutagenesis kit (Stratagene, La Jolla,
CA). Recombinant adenovirus vectors were propagated in HEK293
cells and collected in phosphate-buffered saline as described by the
manufacture (Stratagene). Viral stocks plaque-titered on HEK293
cells and replication incompetence were verified using HeLa cells.
Adenoviral infection
Subconfluent cells were infected for 2 hours with AdNull, AdLacZ,
and AdTie2 (WT, K855A, R849W) at a multiplicity of infection of 40
in serum-free M199 medium. This multiplicity of infection routinely
achieved 100% of infection efficiency in all the cells we tested in
this study. Two hours later, infected cells were fed 2ml of
endothelial growth medium 2 (Cambrex Corp., East Rutherford, NJ)
and incubated for 24 hours before reseeding for various assays or for
harvest of total proteins and total RNA.
Measurement of surface Tie2 by flow cytometry
Subconfluent HUVECs were infected for 24 hours with the indicated
viruses. Following infection, cells were harvested with trypsin-EDTA
followed by immunostaining with anti-Tie2 (1:100) and FITC-
conjugated antibodies. Stained cells were fixed with 1% para-
formaldehyde for subsequent flow cytometry.
Cell proliferation assay
Twenty-four hours after adenoviral infection, HUVECs were seeded
in quadruplicate at a density of 3,000 cells per well in gelatin-coated
96-well tissue culture plate. Cell proliferation was measured using
MTS kits (Promega, Madison, WI) at 48 hours post seeding. The assay
was independently repeated three times.
Tube formation assay
Twenty-four hours following adenoviral infection, HUVECs (2 104
per well) were seeded in duplicate onto 48-well culture dishes
coated with 50 ml of Matrigel (13.4mgml1; BD Biosciences). Tube
formation was observed every 3 hours post seeding with an inverted
Olympus phase-contrast microscope, and five high-power fields at
 100 magnifications were imaged randomly by using Olympus
DP12 digital camera. The vessel length for each treatment was
quantified by a software developed by Dr YN Sun at National Cheng
Kung University. This experiment was independently repeated three
times.
Apoptosis assay
Virus-infected HUVECs were induced to undergo apoptosis via
starvation in serum-free M199 medium for 24 hours, prior to being
labeled with annexin V–FITC and propidium iodide apoptosis kits
(Strong Biotech Corp., Taipei, Taiwan). The starved cells were with
labeled Annexin V–FITC and propidium iodide apoptosis kits (Strong
Biotech Corp.) and analyzed with FACSCalibur flow cytometer. This
experiment was independently repeated three times.
Nuclear and cytosol fractionation
Adenovirus-infected cells were washed with phosphate-buffered
saline and harvested in lysis buffer (10mM Tris-HCl, pH 6.8, 10mM
NaCl, 3mM MgCl2, 0.05% nonidet-P40, 1mM EGTA, 1mM NaVO4,
50mM NaF, and 1 nM okadaic acid) containing protease inhibitors.
Following lysate centrifugation at 20,800 g for 15minutes at 4 1C, the
supernatant was collected for cytosolic fraction. The pellet was
subsequently washed with buffers I and II (I: 10mM HEPES, pH 6.8,
25mM NaCl, 3mM MgCl2, 300mM sucrose, 1mM EGTA, 1mM
NaVO4, and 50mM NaF; II: 1M sucrose, 1mM NaVO4, and 50mM
NaF) followed by centrifugation at 2,700 g for 5minutes at 4 1C. The
resulting pellet was extracted with an extraction buffer (20mM
HEPES, pH 7.9, 300mM NaCl, 1.5mM MgCl2, 0.2mM EDTA, 1mM
NaVO4, 0.1mM b-glycerophosphate, 50mM NaF, and 1 nM okdadaic
acid) on ice for 30minutes. After centrifugation at 20,800 g for
15minutes at 4 1C, the supernatant was stored as a nuclear extract
for subsequent studies.
Immunofluorescence microscopy
Adenovirus-infected cells grown on coverslips were fixed with 4%
paraformaldehye containing 0.5mM sucrose and blocked with 2%
BSA in phosphate-buffered saline. Anti-p-STAT1(Y701) and FITC-
conjugated secondary antibodies were used to detect phosphotyr-
osyl STAT1 in the nuclei. 406-Diamidino-2-phenylindole was used as
a nuclear stain. The image was taken at  300 original magnification
by fluorescence microscopy.
Western blotting and immunoprecipitation
The protein concentration in cell lysate was measured by Bradford
protein assay. Equal amounts of total protein were separated by SDS-
PAGE and blotted onto polyvinylidene difluoride membrane. Protein
blots were hybridized with the indicated primary antibody of interest
and then with secondary antibody, followed by detection with
Immobilon Western system (Millipore Corp., Billerica, MA). For
immunoprecipitation, protein lysates were prepared with the
appropriate lysis buffer containing protease and phosphatase
inhibitors, followed by centrifugation at top speed for 15minutes.
Immunocomplexes were collected with the antibody of interest and
protein Gþ /A-agarose beads, followed by western blot analysis as
described.
Transient transfection and luciferase-reporter assay
Transient transfection was performed using Lipofectamine 2000
(Invitrogen). Briefly, HUVECs were co-transfected with pJEF vector
or Tie2-variant expression vector (400 ng) together with IRF1-
promoter-driven luciferase reporter (200 ng) and pCMV-bgal
(20 ng). Twenty hours after transfection, cells were lysed and
harvested for luciferase and b-galactosidase measurement using
Dual-light Luciferase and b-galactosidase Reporter Gene Assay
System (Tropix, Bedford, MA). Following normalization to
b-galactosidase activity to correct for transfection efficiency,
promoter activity was expressed as relative luciferase unit.
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Data analysis
Results are shown as means±SD. One-way analysis of variance
Dunnett’s paired t-test was used for statistical significance between
two groups, and P-value was considered significant when it was
o0.05.
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SUPPLEMENTARY MATERIAL
Figure S1. The effect of ectopic Tie2 expression on cell migration and
adhesion.
Figure S2. The effect of kinase inhibitors on STAT1 tyrosine phosphorylation.
Figure S3. The effect of ectopic Tie2 expression in the activation of MAPK
family.
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